Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 5, keine Gesamtzahl für „haematological“
Suchtreffer
Begriffe & Kennungen
Ituxredi · 4.8 · Haematologic adverse reactions In clinical trials with rituximab monotherapy given for 4 weeks, haematological
Eintrag öffnenJakavi · 4.8 · Haematological adverse drug reactions (any Common Terminology Criteria for Adverse Events [CTCAE] grade) inclu
Eintrag öffnenJakavi · 4.8 · Haematological adverse reactions (any CTCAE grade) included anaemia (61.8%), thrombocytopenia (25.0%) and neut
Eintrag öffnenJakavi · 4.8 · Haematological laboratory abnormalities identified as adverse drug reactions in REACH2 (adult and adolescent p
Eintrag öffnenJakavi · 4.8 · Haematological laboratory abnormalities identified as adverse drug reactions in REACH2 (adult and adolescent p
Eintrag öffnenJakavi · 4.8 · Haematological laboratory abnormalities identified as adverse drug reactions in REACH3 (adult and adolescent p
Eintrag öffnenJakavi · 4.8 · Haematological laboratory abnormalities identified as adverse drug reactions in REACH3 (adult and adolescent p
Eintrag öffnenJakavi · 4.8 · The most frequent non-haematological adverse drug reactions in REACH2 (adult and adolescent patients) and in t
Eintrag öffnenJakavi · 4.8 · The most frequent non-haematological adverse drug reactions in REACH2 (adult and adolescent patients) and in t
Eintrag öffnenJakavi · 4.8 · The most frequent non-haematological adverse drug reactions in REACH3 (adult and adolescent patients) and in t
Eintrag öffnenJakavi · 4.8 · The most frequent non-haematological adverse drug reactions in REACH3 (adult and adolescent patients) and in t
Eintrag öffnenJakavi · 4.8 · The most frequent non-haematological laboratory abnormalities identified as adverse drug reactions in REACH2 (
Eintrag öffnenJakavi · 4.8 · The most frequent non-haematological laboratory abnormalities identified as adverse drug reactions in REACH2 (
Eintrag öffnenJakavi · 4.8 · The most frequent non-haematological laboratory abnormalities identified as adverse drug reactions in REACH3 (
Eintrag öffnenJakavi · 4.8 · The most frequent non-haematological laboratory abnormalities identified as adverse drug reactions in REACH3 (
Eintrag öffnenJakavi · 4.8 · The three most frequent non-haematological adverse drug reactions were bruising (33.3%), other bleeding (inclu
Eintrag öffnenJakavi · 4.8 · The three most frequent non-haematological adverse reactions were weight gain (20.3%), dizziness (19.4%) and h
Eintrag öffnenJakavi · 4.8 · The three most frequent non-haematological laboratory abnormalities (any CTCAE grade) identified as adverse re
Eintrag öffnenJakavi · 4.8 · The three most frequent non-haematological laboratory abnormalities identified as adverse reactions were incre
Eintrag öffnenJevtana · 4.8 · Table 2: Reported adverse reactions and haematological abnormalities with cabazitaxel in combination with pred
Eintrag öffnen